Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis-response to comments by Ranzani et al.

Muriel Rabilloud; C. Guérin

doi:10.1007/s00134-016-4548-4

Article Dans Une Revue Intensive Care Medicine Année : 2016

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis-response to comments by Ranzani et al.

(1) ,

1

Muriel Rabilloud

Fonction : Auteur
PersonId : 181462
IdHAL : muriel-rabilloud-ferrand
ORCID : 0000-0003-1324-0356
IdRef : 170401731

Biostatistiques santé [LBBE]

CV

C. Guérin

Fonction : Auteur

Domaines

Sciences du Vivant [q-bio]

Lauriane Pillet : Connectez-vous pour contacter le contributeur

https://univ-lyon1.hal.science/hal-02049891

Soumis le : mardi 26 février 2019-16:45:13

Dernière modification le : dimanche 19 mai 2024-03:09:56

Dates et versions

hal-02049891 , version 1 (26-02-2019)

Identifiants

HAL Id : hal-02049891 , version 1
DOI : 10.1007/s00134-016-4548-4

Citer

Muriel Rabilloud, C. Guérin. Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis-response to comments by Ranzani et al.. Intensive Care Medicine, 2016, 42, pp.2121-2122. ⟨10.1007/s00134-016-4548-4⟩. ⟨hal-02049891⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-LYON1 BIOENVIS LBBE UDL

23 Consultations

0 Téléchargements

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis-response to comments by Ranzani et al.

Domaines

Dates et versions

Identifiants

Citer

Exporter

Collections

Altmetric

Partager